MON2

Chr 12

MON2 regulator of endosome-to-Golgi trafficking

Predicted to enable guanyl-nucleotide exchange factor activity. Predicted to be involved in Golgi to endosome transport; protein targeting to vacuole; and retrograde transport, endosome to Golgi. Located in Golgi apparatus and early endosome membrane. [provided by Alliance of Genome Resources, Jun 2026]

OMIMResearchGenerating clinical summary…

Clinical highlights

Interpreting a novel variant
This gene is strongly intolerant of loss-of-function variation in the population, so LoF variants warrant close attention. No curated mechanism annotation is available — see the mechanism card for the computational prediction and its caveats.Based on population constraint only.
0
Active trials
8
Pubs (1 yr)
—
P/LP submissions
—
P/LP missense
0.32
LOEUF· LoF intol.
—
Mechanism

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Dual constrained — LoF & missense intolerant
LoF Constraint?
0.32LOEUF
pLI 0.594
Z-score 6.88
OE 0.22 (0.15–0.32)
Highly constrained

Highly LoF-intolerant (top ~10% of genes)

Missense Constraint?
3.20Z-score
OE missense 0.69 (0.65–0.74)
607 obs / 873.4 exp
Constrained

Highly missense-constrained (top ~0.1%)

Observed / Expected Ratios?
LoF OE?0.22 (0.15–0.32)
0≤0.351.4
Missense OE?0.69 (0.65–0.74)
0≤0.61.4
Synonymous OE?0.98
0≤1.21.6
LoF obs/exp: 20 / 90.8Missense obs/exp: 607 / 873.4Syn Z: 0.33

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

MON2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →